Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide for prevention of bronchopulmonary dysplasia in very preterm infants
2009-012203-26Phase 3Completed
- Sponsor
- University Children’s Hospital
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Inhaled budesonide with Placebo control (2 arms). Primary endpoint: Primary composite endpoint. Started Jun 2009; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2009-012203-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012203-26.